text.skipToContent text.skipToNavigation

PartoSure Test

To aid in the diagnosis of preterm labor (PTL)
  • Presence of semen does not interfere with test performance
  • Speculum examination and external reader not required 
  • Results in 5 minutes (1)
     
The PartoSure Test is a rapid, non-instrumented, qualitative immunochromatographic test for the in vitro detection of placental alpha microglobulin-1 (PAMG-1) in vaginal secretions of pregnant women. The device is designed as an aid to rapidly assess the risk of preterm delivery in ≤7 or ≤14 days from the time of cervicovaginal sample collection in pregnant women with signs and symptoms of early preterm labor, intact amniotic membranes and minimal cervical dilatation (≤ 3 cm), sampled between 20 weeks, 0 days and 36 weeks, 6 days gestation. Want to try this solution for the first time? Request a quote for a trial kit.

The PartoSure Test are intended for in vitro diagnostic use.


  1. PartoSure Test Instructions for Use. QIAGEN, 2018.
  2. Alfirevic et al. Ultrasound Obstet Gynecol 2007; 29: 47–50.
  3. Eds. Howson CP, Kinney MV, Lawn JE. March of Dimes, PMNCH, Save the Children, World Health Organization. Born Too Soon: The Global Action Report on Preterm Birth. 2012.
  4. Antenatal Corticosteroids Revisited: Repeat Courses. NIH Consensus Statement: NIH, 2000.
  5. Petrunin DD, Griaznova IM, Petrunina IA, Tatarinov IS. Immunochemical identification of organ specific human placental alpha globulin and its concentration in amniotic fluid. Akush Gynecol (Mosk) 1977;(1):62–4.
  6. Petrunin DD, Graznova IM, Petrunina IA, & Tatarinov IS. Comparative immunochemical and physiochemical characteristics of chorionitic alpha-1 and alpha-2 microglobulins in human placenta. Bulletin of Experimental Biology and Medicine. 1978;(5):600-602.
  7. Lee MS, Romero R, Park JW, Kim SM, Park CW, Korzeniewski S, Chaiworapongsa T, Yoon BH. The clinical significance of a positive Amnisure test™ in women with preterm labor. J Matern Fetal Neonatal Med. 2012 Sep;25(9):1690-8